Managing AEs in Cabo Nivo Combination Therapy for Advanced RCC

News
Video

Expert oncologists discuss the nuances of managing toxicities associated with Cabozantinib and Nivolumab combination therapy for advanced renal cell carcinoma (RCC).

Related Videos
Hans C. Lee, MD
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
Jeremy L. Ramdial, MD, assistant professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Neil D. Gross, MD, FACS
Michael J. Overman, MD, The University of Texas MD Anderson Cancer Center,
Eleonora Dondossola, PhD
A panel of 5 experts on multiple myeloma
A panel of 5 experts on multiple myeloma
A panel of 5 experts on multiple myeloma